Corrigendum to “reported Adverse Events in a Multicenter Cohort of Patients Ages 6-18 Years with Cystic Fibrosis and at Least One F508dek Allele Receiving Elexacaftor/Tezacaftor/Ivacaftor”. J Pediatr. 2024 Jun 28; 274:114176
The Journal of Pediatrics(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined